As a healthcare company proactively participating in the COVID-19 combat, Biohit (Hefei) was invited to be present at the China-Spain Biomed...

We're very pleased to announce that we have been awarded the CE marking for our SARS-CoV-2 Antigen Rapid Test (Colloidal Gold Method). ...

Biohit (Hefei) moved to new site in the early February. This relocation is part of our strategic initiative that focuses on ope...

On September 29th, 2020, the SARS-CoV-2 antigen rapid test kit (fluorescence immunochromatography) independently developed and manufactur...

The SARS-CoV-2 antigen quantitative assay kit (enzyme-linked immunoassay) independently developed and produced by Biohit Healthcare (Hefe...

On March 18th, the SARS-CoV-2 IgM/IgG Antibody Test Kit(Colloidal Gold Method) produced by Biohit Healthcare(Hefei) Co., Ltd. passed the ...

On June 18th 2020, Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit (Colloidal Gold Method) obtained U.S. Food and Drug Administratio...

On June 12th, the SARS-CoV-2 Antigen quantitative assay kit (enzyme-linked immunoassay) produced by Biohit Healthcare(Hefei) Co., Ltd. pa...